|
Vaccine Detail
B. anthracis PA protein Vaccine with TMDP |
Vaccine Information |
- Vaccine Name: B. anthracis PA protein Vaccine with TMDP
- Target Pathogen: Bacillus anthracis
- Target Disease: Anthrax
- Vaccine Ontology ID: VO_0004270
- Type: Subunit vaccine
- Status: Research
- Antigen: B. anthracis PA protein (Ivins et al., 1992).
- Adjuvant:
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Guinea pig Response
- Host Strain: Hartley
- Vaccination Protocol: Several adjuvant preparations combined with PA were compared with each other and with MDPH-PA with respect to protection and elicitation of anti-PA antibody. In the first experiment, guinea pigs received one or more injections of each preparation (Ivins et al., 1992).
- Challenge Protocol: Guinea pigs were challenged i.m. 10 weeks after the first immunization with 7,300 (73 LD50) of B. anthracis Ames spores (Ivins et al., 1992).
- Efficacy: 12/18 guinea pigs survived challenge after immunization with 1 dose of PA + TMDP and 13/20 survived after 2 doses of PA + TMDP (Ivins et al., 1992).
|
References |
Ivins et al., 1992: Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infection and immunity. 1992; 60(2); 662-668. [PubMed: 1730501].
|
|